Progress of internal mammary sentinel lymph node biopsy in patients with breast cancer

doi:10.3877/cma.j.issn.1674-0793.2013.04.016

Abstract

Abstract:

The status of internal mammary lymph node (IMLN) is an independent prognostic factor for breast cancer patients, and it is an important reference for the accurate nodal staging. In patients with IMLN metastases, the prognosis would become unfavorable. Internal mammary sentinel lymph node biopsy (IM-SLNB) via intercostal space is a minimally invasive surgical procedure compared with internal mammary nodal chain dissection. Recently, with the development of sentinel lymph node biopsy (SLNB) and the appearance of modified injection technique, the detection rate of internal mammary hotspots in lymphoscintigraphy has been improved significantly, IM-SLNB via intercostal spaces can access the status of IMLN with minimal risk. IM-SLNB procedure can improve the nodal staging system, and it will contribute to the individualized treatment for breast cancer patients.

Key words: Breast neoplasms, Internal mammary lymph node, Sentinel lymph node biopsy

Bin-bin CONG, Peng-fei QIU, Yong-sheng WANG. Progress of internal mammary sentinel lymph node biopsy in patients with breast cancer[J]. Chinese Archives of General Surgery(Electronic Edition), 2013, 07(04): 311-314.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhptwkxwx.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-0793.2013.04.016

https://zhptwkxwx.cma-cmc.com.cn/EN/Y2013/V07/I04/311

References 28

1	Lee SK, Kim S, Choi MY, et al. The clinical meaning of intramammary lymph nodes. Oncology, 2013, 84(1): 1-5.
2	Madsen E, Gobardhan P, Bongers V, et al. The impact on postsurgical treatment of sentinel lymph node biopsy of internal mammary lymph nodes in patients with breast cancer. Ann Surg Oncol, 2007, 14(4): 1486-1492.
3	He Q, Zhuang D, Tian J, et al. Surgical approach to internal mammary sentinel node biopsy. J Invest Surg, 2010, 23(6): 321-326.
4	Domènech-Vilardell A, Bajén MT, Benít ez AM, et al. Removal of the internal mammary sentinel node in breast cancer. Nucl Med Commun, 2009, 30(12): 962-970.
5	van der Ent FW, Kengen RA, van der Pol HA, et al. Halsted revisited: internal mammary sentinel lymph node biopsy in breast cancer. Ann Surg, 2001, 234(1): 79-84.
6	Heuts EM, van der Ent FW, Hulsewé KW, et al. Results of tailored treatment for breast cancer patients with internal mammary lymph node metastases. Breast, 2009, 18(4): 254-258.
7	Postma EL, van Wieringen S, Hobbelink MG, et al. Sentinel lymph node biopsy of the internal mammary chain in breast cancer. Breast Cancer Res Treat, 2012,134(2): 735-741.
8	Noushi F, Spillane AJ, Uren RF, et al. Internal mammary node metastasis in breast cancer: Predictive models to determine status & management algorithms. Eur J SurgOncol, 2010, 36(1): 16-22.
9	Veronesi U, Cascinelli N, Greco M, et al. Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes. Ann Surg, 1985, 202(6): 702-707.
10	Livingston SF, Arlen M. The extended extrapleural radical mastectomy: Its role in the treatment of carcinoma of the breast. Ann Surg, 1974, 179(3): 260-265.
11	Veronesi U, Marubini E, Mariani L, et al. The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomised trial. Eur J Cancer, 1999, 35(9): 1320-1325.
12	Bourre JC, Payan R, Collomb D, et al. Can the sentinel lymph node technique affect decisions to offer internal mammary chain irradiation? Eur J Nucl Med Mol Imaging, 2009, 36(5): 758-764.
13	Park C, Seid P, Morita E, et al. Internal mammary sentinel lymph node mapping for invasive breast cancer: Implications for staging and treatment. Breast J, 2005,11(1): 29-33.
14	Nieweg OE, Jansen L, Valdés Olmos RA, et al. Lymphatic mapping and sentinel lymph node biopsy in breast cancer. Eur J Nucl Med, 1999, 26(4 Suppl): S11-16.
15	McMasters KM, Wong SL, Tuttle TM, et al. Preoperative lymphoscintigraphy for breast cancer does not improve the ability to identify axillary sentinel lymph nodes. Ann Surg, 2000, 231(5): 724-731.
16	Shimazu K, Tamaki Y, Taguchi T, et al. Lymphoscintigraphic visualization of internal mammary nodes with subtumoral injection of radiocolloid in patients with breast cancer. Ann Surg, 2003, 237(3): 390-398.
17	Heuts EM, van der Ent FW, von Meyenfeldt MF, et al. Internal mammary lymph drainage and sentinel node biopsy in breast cancer-A study on 1008 patients. Eur J Surg Oncol, 2009, 35(3): 252-257.
18	Qiu PF, Liu JJ, Liu YB, et al. A modified technology could significantly improve the visualization rate of the internal mammary sentinel lymph nodes in breast cancer patients. Breast Cancer Res Treat, 2012, 136(1): 319-321.
19	Qiu PF, Zhao RR, Liu YB, et al. Internal mammary sentinel lymph node biopsy should still be performed, especially in the patient with clinically positive axillary lymph nodes. Breast, 2013 Jul 6.[Epub ahead of print]
20	陈捷鑫，林鹏，樊卫, 等. 乳腺癌内乳淋巴结活检的临床研究. 癌症, 2007, 26(2): 172-177.
21	Avisar E, Molina MA, Scarlata M, et al. Internal mammary sentinel node biopsy for breast cancer. Am J Surg, 2008, 196(4): 490-494.
22	García-Villanueva A, Collado-Guirao MV, Rojo-Blanco R, et al. Internal mammary chain sentinel biopsy in invasive breast cancer: an investigational procedure? Breast J, 2009, 15(3): 313-314.
23	Lagarde SM, Tanis PJ, van der Meij S, et al. Chylous fistula after internal mammary chain sentinel node biopsy. Am Surg, 2010, 76(11): 1309-1311.
24	Sacchini G, Borgen PI, Galimberti V, et al. Surgical approach to internal mammary lymph node biopsy. J Am Coll Surg, 2001, 193(6): 709-713.
25	邱鹏飞，王永胜. 乳腺癌内乳区淋巴结研究进展. 肿瘤研究与临床, 2011, 23(12): 793-795.
26	Whelan TJ, Olivotto I, Ackerman I, et al. NCIC-CTG MA.20: an intergroup trial of regional nodal irradiation in early breast cancer. J Clin Oncol, 2011, 29: 779S.
27	Poortmans P, Kouloulias VE, Venselaar JL, et al. Quality assurance of EORTC trial 22922/10925 investigating the role of internal mammary-medial supraclavicular irradiation in stage I-III breast cancer: the individual case review. Eur J Cancer, 2003, 39(14): 2035-2042.
28	Coombs NJ, Boyages J, French JR, et al. Internal mammary sentinel nodes: ignore, irradiate or operate? Eur J Cancer, 2009, 45(5): 789-794.

[1]	Yaping Jia, Shu'e Zeng. Ultrasound and pathological characteristics of breast metaplastic carcinoma containing squamous cell carcinoma components [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(08): 844-848.
[2]	Wei Tang, Rongquan He, Suning Huang. Application of deep learning in imaging for diagnosis, treatment and prognosis prediction of breast cancer [J]. Chinese Journal of Breast Disease(Electronic Edition), 2023, 17(06): 323-328.
[3]	Xia Kang, Hao Tian, Jin Qian, Yuan Gao, Hongming Miao, Xiaowei Qi. Osteorin attenuates osteolysis during bone metastasis of cancers through inhibiting osteoclastogenesis [J]. Chinese Journal of Breast Disease(Electronic Edition), 2023, 17(06): 329-339.
[4]	Xiaoli Yi, Shasha Hu, Yan Zhang. Impact of HER-2 low expression on response of neoadjuvant chemotherapy and prognosis in breast cancer patients [J]. Chinese Journal of Breast Disease(Electronic Edition), 2023, 17(06): 340-346.
[5]	Jie Shi, Yuntao Li, Haiyan Gao. Prognosis of node-positive luminal A breast cancer patients with neoadjuvant and adjuvant chemotherapy and influencing factors [J]. Chinese Journal of Breast Disease(Electronic Edition), 2023, 17(06): 353-361.
[6]	Jiaxuan Liu, Binghe Xu. Annual advancement of clinical research on breast cancer in China [J]. Chinese Journal of Breast Disease(Electronic Edition), 2023, 17(05): 259-265.
[7]	Chengcai Yao, Changchun Liu, Wenjian Huang, Ming Chen. Single-port non-lipolysis fluorescence-guided laparoscopy for axillary lymph node biopsy in early breast cancer [J]. Chinese Journal of Breast Disease(Electronic Edition), 2023, 17(05): 266-271.
[8]	Bohui Shi, Xiping Ding, Lian Wang, Rong Li, Pingli Guo, Jing Qi, Yao Chen, Na Hao, Yu Ren. Summary of best evidences for prevention and treatment of subcutaneous seroma after breast cancer surgery [J]. Chinese Journal of Breast Disease(Electronic Edition), 2023, 17(05): 277-284.
[9]	Yaping Wang, Jing Fan, Niuniu Hou, Rui Ling. Clinical significance of tumor-infiltrating lymphocytes in HER-2-positive early breast cancer [J]. Chinese Journal of Breast Disease(Electronic Edition), 2023, 17(04): 203-209.
[10]	Wenbo Gao, Ming Li, Yunhao Zhang. Prognostic value and clinical significance of advanced lung cancer inflammation index in patients with triple negative breast cancer [J]. Chinese Journal of Breast Disease(Electronic Edition), 2023, 17(04): 210-217.
[11]	Qinqin Zhang, Junnan Wang, Houmin Lin, Ying Wu, Yuemei Tan, Mingzhou Li, Junfei Jin, Ningxia Wang, Yong Hong. Bioinformatics analysis of differential expression and clinical significance of complement 3 in breast cancer [J]. Chinese Archives of General Surgery(Electronic Edition), 2023, 17(04): 271-277.
[12]	Qingyan Yan, Xiaomei Yong, Hong Luo, Min Du. Prognostic factors and survival analysis of multicenter elderly patients with metastatic breast cancer [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(06): 636-638.
[13]	Zhiming Li, Chenming Guo, Xiaochen Zhuang, Xueqin Hou, Junxi Gao. Comparative study of qualitative and quantitative indicators of contrast-enhanced ultrasound in early breast cancer [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(06): 639-643.
[14]	Hongbo Qu, Fang Zhu, Zhe Xu, Nan Wu, Jianhuai He, Xianming Wang. Application of subclavian lymph node dissection through intermuscular approach in locally advanced breast cancer [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(05): 510-513.
[15]	Shan Chen, Zhiqiang Hu, Yueming Zhang, Ding Tang, Meng Li, Shuai Zhao. Expression of Orai1 and Orai3 in breast cancer and their correlation with pathological indexes [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(05): 514-517.

Please choose a citation manager

Content to export